Indication
5 years of follow-up after transplant
1 clinical trial
1 product
Clinical trial
De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression WithdrawalStatus: Completed, Estimated PCD: 2022-02-01
Product
Immunosuppressive